Dennis Dizon Balajadia

Dennis Dizon Balajadia

Active Director Director DIN 02655964
DIN 02655964 First appointment Sep 2005 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 2 active board seats
Total affiliations 2 Since Sep 2005
Shareholding value •••• Premium profile

About Dennis Dizon Balajadia

Data last updated:

Dennis Dizon Balajadia is a Director at Steril-Gene Life Sciences Private Limited (since 2009) and Director at Lloyd Laboratories Private Limited (since 2005). The companies operate in Pharma. The 2 current companies with reported revenue have a combined latest revenue of ₹438 Cr; the largest is Steril-Gene Life Sciences Private Limited at ₹404 Cr (FY 2025).

DIN 02655964
Primary Designation Director
Industry Pharma
First Appointment 20 Sep 2005
Oldest Company Age 21 yrs
Largest company Steril-Gene Life Sciences Private Limited · ₹404 Cr (FY 2025)
Combined revenue ₹438 Cr across 2 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director04 Dec 20092007₹404 Cr (FY 2025)Active
Lloyd Laboratories Private Limited U24231TN2005PTC057548
Director20 Sep 20052005₹33.86 Cr (FY 2024)Active

Directorship timeline

Open interactive timeline →
Steril-Gene Life Sciences Private Limited
Lloyd Laboratories Private Limited
Premium access

Shareholding and investment profile for Dennis Dizon Balajadia

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Dennis Dizon Balajadia

Dennis Dizon Balajadia currently holds 2 directorships: Steril-Gene Life Sciences Private Limited (Director, since 04 Dec 2009, revenue ₹404 Cr (FY 2025)); Lloyd Laboratories Private Limited (Director, since 20 Sep 2005, revenue ₹33.86 Cr (FY 2024)).

Dennis Dizon Balajadia was first appointed on 20 Sep 2005 as Director at Lloyd Laboratories Private Limited. The most recent appointment on record is 04 Dec 2009 at Steril-Gene Life Sciences Private Limited.

The 2 current companies of Dennis Dizon Balajadia that report revenue have a combined latest revenue of ₹438 Cr: Steril-Gene Life Sciences Private Limited ₹404 Cr (FY 2025); Lloyd Laboratories Private Limited ₹33.86 Cr (FY 2024).

The current boards of Dennis Dizon Balajadia's companies include Alagappan (Steril-Gene Life Sciences Private Limited), Chanpreet Singh Anand (Steril-Gene Life Sciences Private Limited), Dick Dizon Balajadia (Steril-Gene Life Sciences Private Limited), Lloyd Dizon Balajadia (Steril-Gene Life Sciences Private Limited), Manohar Srivignesh (Steril-Gene Life Sciences Private Limited), Maximo Ponce Balajadia (Steril-Gene Life Sciences Private Limited), among others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available